With renewed grant support from the NIH Clinical and Translational Science Award and the Wisconsin Partnership Program (WPP), ICTR will fund 21 awards totaling $1.3 million to support clinical and translational research in Wisconsin. Christine Sorkness, PharmD, ICTR Senior Executive Director, notes,
ICTR is proud to celebrate renewal of our competitive grants from NIH and WPP by extending our uninterrupted record of funding awards that catalyze clinical and translational research and engage UW and Marshfield investigators, collaborators, and community partners. Importantly, the Pilot Awards Program continues to emphasize innovative research methods, team science, health equity, and impact.
As in previous years, we are partnering with UW departments and centers to sponsor specific awards, via our co-funding model. This approach allow both us and our partners to leverage scarce research funds to assist as many investigators as possible.
Co-funded awards are subject to an identical rigorous scientific review process, but post-review, institutional partners have the opportunity to select projects for co-funding that strategically align with their individual research priorities. The 2022 co-funding partnerships include the UW Carbone Cancer Center and the Department of Medicine’s Division of Geriatrics.
This year’s pilot portfolio includes Translational Basic & Clinical Pilot Awards (10), Novel Methods in Translational Science Pilot Grant Awards (4), Clinical & Community Outcomes Research Awards (4), Dissemination & Implementation Research Awards (2), and a Stakeholder & Patient Engaged Research Award. Awardees and their home departments span the entire UW campus, not just the schools and college that comprise the ICTR partnership (Engineering, Medicine & Public Health, Nursing, Pharmacy and Veterinary Medicine).